RCMC
ARRY

Rubric Capital Management (Connecticut)’s Array Biopharma Inc ARRY Stock Holding History

Rubric Capital Management (Connecticut)’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-600,000
Closed -$2.53M – 38
2015
Q4 		$2.53M Buy
+600,000
New +$2.74M 0.22% 47

Other funds holding ARRY

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Rubric Capital Management (Connecticut)'s ARRY Position: Q1 2016 in Review

Rubric Capital Management (Connecticut) sold out of Array Biopharma Inc (ARRY) in Q1 2016, closing a stake of 600,000 shares — an estimated $2.53M sold.

Rubric Capital Management (Connecticut) first reported a position in ARRY in Q4 2015 and held it in 1 quarter. The position peaked at $2.53M in Q4 2015. 132 funds tracked by Wall St. Rank hold ARRY as of Q1 2016.

  • Rubric Capital Management (Connecticut) reported no remaining Array Biopharma Inc position as of Q1 2016 after selling out during the quarter.
  • Rubric Capital Management (Connecticut) sold 600,000 Array Biopharma Inc shares in Q1 2016, an estimated $2.53M.
  • Rubric Capital Management (Connecticut) first reported a position in Array Biopharma Inc in Q4 2015 and held it in 1 quarter.
  • Rubric Capital Management (Connecticut)'s Array Biopharma Inc position peaked at $2.53M in Q4 2015.
  • 132 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2016.

Based on Rubric Capital Management (Connecticut)'s 13F filing for Q1 2016, filed 16 May 2016.